| Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
|---|
| 08/06/2008 | EP1301460B1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 08/06/2008 | CN101235067A Process for preparing plant sterol ester |
| 08/06/2008 | CN101235066A Novel toosendan fruit peel extract |
| 08/06/2008 | CN100408593C Cholest compound, synthetic method and its use |
| 08/06/2008 | CN100408592C Fractionation of phytosterol esters in oil |
| 08/05/2008 | CA2272721C Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds |
| 08/05/2008 | CA2207136C New 1 or 6-hydroxyl steroids, their preparation process, their application as drugs and the pharmaceutical compositions surrounding them |
| 07/31/2008 | WO2008091540A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 07/31/2008 | US20080182832 orphan nuclear Receptor agonists; chenodeoxycholic acid, ursodeoxycholic acid or cholic acid derivatives; atherosclerosis, arteriosclerosis, dyslipidemia, hypercholesterolemia, and hypertriglyceridemia.atherosclerosis, arteriosclerosis, hypercholestremia, and hyperlipidemia |
| 07/31/2008 | CA2676417A1 Tgr5 modulators and methods of use thereof |
| 07/30/2008 | EP1776377B1 Novel steroid agonist for fxr |
| 07/30/2008 | CN101233145A Agent for amelioration of insulin resistance |
| 07/30/2008 | CN101230081A Extraction method for separating antineoplastic tri-terpenoid from capsule of weeping forsythia and use thereof |
| 07/30/2008 | CN101230080A simulated moving bed chromatography separation of 20(S) and 20(R)-ginsenoside Rg3 enantiomer |
| 07/30/2008 | CN101229199A Integrative extract method of multi-active ingredient in cordyceps militaris mycelium |
| 07/23/2008 | EP1947108A1 TGR5 modulators and methods of use thereof |
| 07/23/2008 | EP1664078B1 Process for the recovery of a phytolipid composition |
| 07/23/2008 | CN101225099A Method for preparing compound containing 2,3-or3,4-double-bond steroid |
| 07/17/2008 | WO2008084561A1 HELICOBACTER PYLORI GROWTH INHIBITOR CONTAINING α-N-ACETYLGLUCOSAMINYL-BINDING MONOSACCHARIDE DERIVATIVE |
| 07/16/2008 | CN101220075A Preparation method for 7-dehydrochol esterol |
| 07/16/2008 | CN101220074A Method for extracting bile acid from animal bile |
| 07/16/2008 | CN101220073A Synthesis of polyhydroxy ocean steroid (25R)-5 alpha-cholesteric-2 beta,3 alpha,26-triol |
| 07/16/2008 | CN100402546C Steroid compounds with anti-tumor activity |
| 07/10/2008 | US20080166301 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; osteoporosis; endometriosis; benign prostatic hyperplasia; cardiovascular disorders; acne |
| 07/09/2008 | EP1940775A2 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals |
| 07/09/2008 | CN101215311A Method for producing ursodesoxycholic acid from 86% of chenodeoxycholic acid |
| 07/09/2008 | CN101215310A Method for producing ursodesoxycholic acid from 98.0% of cholic acid of cattle and sheep |
| 07/09/2008 | CN101215309A Method for producing chenodeoxycholic acid from 98% of cholic acid of cattle and sheep |
| 07/09/2008 | CN101215308A Method for producing ursodeoxycholic acid by using swine bladder as raw material |
| 07/03/2008 | US20080159971 Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agent |
| 07/02/2008 | EP1938149A2 Low activation energy dissolution modification agents for photoresist applications |
| 07/02/2008 | CN101212976A Visceral fat accumulation inhibitor |
| 07/02/2008 | CN100398633C Method for non-catalytic lanolin hydrolyzed preparation of lanolin acid and lanolin alcohol using in near critical water medium |
| 07/02/2008 | CN100398109C Steroid derived antibiotics |
| 06/26/2008 | WO2008074216A1 Sterols modified by polyethylene glycol, the preparation and the use thereof |
| 06/25/2008 | CN100396694C Triterpene compounds with ring breakage in C3 and C4 position and their use for prevention and treatment of AIDS |
| 06/19/2008 | WO2008071960A2 Methods of increasing neurogenesis |
| 06/19/2008 | WO2008071009A1 Novel ligand guided block copolymers for targeted drug delivery |
| 06/18/2008 | EP1173464B1 Process for preparing a phytosterol composition |
| 06/18/2008 | CN101203526A Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid |
| 06/18/2008 | CN101200752A Method for separation and preparation of eburicoic acid compound by using hirschioporus versatilis fermentation liquor |
| 06/12/2008 | WO2007111994A3 Compounds and methods for treatment of disorders associated with er stress |
| 06/12/2008 | US20080138450 Recovering a phytolipid from a vegetable oil by-product by distillation, the product comprising squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax; useful as an emollient and also may be incorporated into foods, beverages, and nutraceuticals |
| 06/12/2008 | US20080138285 for vascular lesion imaging and for diagnosing arteriosclerosis, ischemia with X-ray angiography and positron emission tomography; fluorinated steroid ester, glyceride compounds, phosphatidylcholine, and phosphatidylserine as membrane components of liposome |
| 06/11/2008 | EP1930341A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930013A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1929313A2 Methods to identify therapeutic agents |
| 06/11/2008 | CN101195649A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
| 06/10/2008 | CA2325933C Fatty acid derivatives of bile acids and bile acid derivatives |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/04/2008 | EP1927360A1 Visceral fat accumulation inhibitor |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 06/03/2008 | US7381566 Adding to sodium hydroxide and stirring; biosensors, nanoelectronics and transporting bioactive products |
| 05/29/2008 | WO2008041003A3 Hydroxycholesterols and its prodrugs for the treatment of insulin resistance and disorers asociated therewith |
| 05/28/2008 | EP1268511B1 Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst |
| 05/28/2008 | CN101186630A Fast preparation method for ganoderma lucidum triterpene compounds and products thereof |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/21/2008 | CN101182331A Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof |
| 05/21/2008 | CN100389123C Synthesis of 26-bromo-16, 22-dioxy-cholesterol compounds |
| 05/21/2008 | CN100389122C Cholesterol derivative containing azobenzene group, and its synthesizing method and use |
| 05/20/2008 | CA2385410C Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 05/20/2008 | CA2322862C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/15/2008 | US20080114180 High yield synthesis of 21(S)-hydroxy-4,9-gonadien-3,20-diones, synthetic progestinic steroids; hydroxylation of 3,3-alkylendioxy-17 beta -(1-oxoalkyl)-5(10),9(11)-gonadiene with oxaziridine derivative using strong organic base in solvent; decyclization carbonylation in presence of cerium derivative |
| 05/15/2008 | US20080112966 Extracts and Methods Comprising Ganoderma Species |
| 05/14/2008 | EP1921086A1 Antitumor agent |
| 05/14/2008 | CN101177444A Method for extracting momordica grosvenori flavone glycoside from momordica grosvenori |
| 05/14/2008 | CN100387613C Manufacture method of ethyl brassinolide |
| 05/14/2008 | CN100387612C Method for extracting hemsleyadin |
| 05/13/2008 | US7371876 extraction of neutral substances from soaps, removal of components interfering with sterol separation from the neutrals (e.g., impurities), and sterol crystallization from the purified neutral substances; high quality, high purity |
| 05/07/2008 | CN100386339C Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/06/2008 | US7368583 Process for recovery of plant sterols from by-product of vegetable oil refining |
| 05/02/2008 | WO2007039346A3 Low activation energy dissolution modification agents for photoresist applications |
| 04/30/2008 | EP1916255A2 Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound |
| 04/30/2008 | CN101168557A Film separation and purification method for esgoside and extraction method for biological active compound |
| 04/30/2008 | CN101168556A Method for purifying esgoside and extracting biological active compound |
| 04/23/2008 | EP1162977B1 (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for the control of fertility |
| 04/23/2008 | CN100383157C 3beta, 5 alpha, 6 beta, 11 beta tetrahydroxy cholestanol, and its preparing method and use |
| 04/16/2008 | CN100381458C Protopanoxadiol lower alcohol derivatives and process for preparing same |
| 04/15/2008 | CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 04/10/2008 | WO2008041003A2 Hydroxycholesterols and its prodrugs for the treatment of insulin resistance and disorers asociated therewith |
| 04/10/2008 | CA2665380A1 Treatment of insulin resistance and disorders associated therewith |
| 04/08/2008 | CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/03/2008 | WO2008038965A1 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient |
| 04/03/2008 | WO2008008810A3 Process for isolating phytosterols and tocopherols from deodorizer distillate |
| 04/02/2008 | CN100378117C Method for obtaining diol type sinsenoside F2 from ginseng root |
| 04/01/2008 | US7351699 Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent |
| 03/27/2008 | US20080075763 Polycationic sterol derivatives as transfection agents |
| 03/26/2008 | EP1903050A2 A process for the preparation of cholanic acids |
| 03/26/2008 | CN101148468A High efficiency technique for extracting bilirubin and bile acid by using animal bile as raw material |
| 03/25/2008 | CA2467265C Pharmaceutical composition for enhancing immunity, and extract of poria |
| 03/25/2008 | CA2383505C A process for the preparation of 3-amino bile acid derivatives |
| 03/20/2008 | WO2008032980A1 Novel stigmasterol derivative or pharmaceutically acceptable salt thereof, method of producing the same, and composition containing the same to inhibit obesity or to prevent and treat hyperlipidemia |
| 03/19/2008 | CN101143886A Non-organic solvent extraction method for chenodeoxycholic acid in bird gall |
| 03/19/2008 | CN101143147A Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 03/18/2008 | CA2121689C 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use |
| 03/13/2008 | US20080064888 Hydrolysis of swine bile with alkali hydroxide; multiple controlled pH solvent extraction recovery of crude mixture; chromatographic separation; simple, industrial scale; high purity biologically active pharmaceutical ingredients and intermediates |
| 03/12/2008 | CN101139380A Method for producing cholic acid by using bovine and sheep bile |